Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock wave showdown: how many sessions to soothe heel pain?

NCT ID NCT07626723

Symptom relief Sponsor: Kirsehir Ahi Evran Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether having more sessions of shock wave therapy (ESWT) helps people with long-term heel pain (plantar fasciitis) feel better and move easier. About 57 adults with pain lasting at least 3 months will be split into groups getting different numbers of ESWT sessions. Researchers will measure pain, foot function, and quality of life to find the best treatment plan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 57 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-65, both male and female, diagnosed with plantar fasciitis based on anamnesis and physical examination. * Patients must have had symptoms for at least 3 months. * Patients must consent to participate in the study according to the informed consent form. Exclusion Criteria: * Complaint lasting less than 3 months * Having received an injection in the heel area within the last 6 months * Having applied physical therapy modalities to the heel area within the last 6 months * Bilateral complaint * Pregnancy * Malignancy * Epilepsy * History of cardiac pacemaker * Anticoagulant use * History of systemic inflammatory disease * History of fracture or surgery in the lower extremity * Presence of an open wound in the heel area * Hypersensitivity in the patient * Systemic infection in the patient * Uncontrolled hypertension in the patient * Uncontrolled diabetes in the patient * Inability of the patient to cooperate * History of neuromuscular disease affecting balance parameters * Patient's unwillingness to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic plantar fasciitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

plantar fasciitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Extracorporeal shock wave therapy Plantar fasciitis Ultrasonography

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kırşehir Ahi Evran Training and Research Hospital

    Kırşehir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.